Abstract
BackgroundSince 2006, rituximab (RTX) is approved in combination with methotrexate (MTX) for the treatment of rheumatoid arthritis (RA) after failure of tumor necrosis factor-α (TNFα) blocking therapy. A substantial number...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have